Works matching DE "SODIUM-glucose cotransporter 2 inhibitors"

Results: 2204

Response to Letter to the Editor by Bihua Yao and Jianguo Wu.

Published in:

Liver International, 2025, v. 45, n. 6, p. 1, doi. 10.1111/liv.70134

By:

Li, Chang;
Cheung, Ka Shing

Publication type:

Article

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions.

Published in:

Biomedicines, 2025, v. 13, n. 5, p. 1053, doi. 10.3390/biomedicines13051053

By:

Otoda, Toshiki;
Aihara, Ken-ichi;
Takayama, Tadateru

Publication type:

Article

Empagliflozin Leads to Faster Improvement in Arterial Stiffness Compared to Dapagliflozin: A Double-Blind Clinical.

Published in:

Life (2075-1729), 2025, v. 15, n. 5, p. 802, doi. 10.3390/life15050802

By:

González Campos, Erick;
Grover Páez, Fernando;
Ramos Becerra, Carlos Gerardo;
Balleza Alejandri, Luis Ricardo;
Suárez Rico, Daniel Osmar;
Cardona Muñoz, Ernesto Germán;
Pascoe González, Sara;
Ramos Zavala, María Guadalupe;
Beltrán Ramírez, Alberto;
García Galindo, Jesús Jonathan;
Cardona Müller, David

Publication type:

Article

Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes.

Published in:

Life (2075-1729), 2025, v. 15, n. 5, p. 722, doi. 10.3390/life15050722

By:

Yalçın, Nazif;
Aktaş, Selman;
Uyar, Seyit;
Koca, Nizameddin

Publication type:

Article

Diabetes and Alzheimer's Disease.

Published in:

Journal of Diabetes, 2025, v. 17, n. 5, p. 1, doi. 10.1111/1753-0407.70103

By:

Bloomgarden, Zachary

Publication type:

Article

Cardioprotective effects of sodium-glucose transport protein 2 inhibitors in patients with breast cancer and concomitant type 2 diabetes mellitus undergoing chemotherapy.

Published in:

International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2025, v. 21, n. 3, p. 253, doi. 10.22141/2224-0721.21.3.2025.1535

By:

Fedorov, S. V.;
Herashchenko, S. B.;
Kozlova, I. V.;
Bielinskyi, M. V.;
Herashchenko, A. S.;
Roiko, H. D.;
Vahyl, S. A.

Publication type:

Article

DAPAGLIFLOZIN ENHANCES SYSTOLIC AND DIASTOLIC FUNCTION IN CONCORDANCE WITH CLINICAL RESPONSE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION.

Published in:

European Review for Medical & Pharmacological Sciences, 2025, v. 29, n. 5, p. 231

By:

WARDA, A. E. ABOU;
DUARTE, J. D.;
SALEM, M. NABIL;
SALEM, H. F.;
MOHARRAM, A. N.;
ALANAZI, A. S.;
ALZAREA, A. I.;
ALSAHLI, T. G.;
SULTAN, H.;
ALRASHDI, M. A.;
ALTEBAINAWI, A. F.;
IBRAHIM, B. EMIL;
ALNAHRAWI, S. IBRAHIM;
MEGALAA, K. KAMEL;
ZARIF, B.;
SARHAN, R. M.

Publication type:

Article

Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 735, doi. 10.3390/ph18050735

By:

Chen, Jiann-Jy;
Hsu, Chih-Wei;
Hung, Chao-Ming;
Liang, Chih-Sung;
Su, Kuan-Pin;
Carvalho, Andre F.;
Stubbs, Brendon;
Chen, Yen-Wen;
Chen, Tien-Yu;
Lei, Wei-Te;
Zeng, Bing-Yan;
Tseng, Ping-Tao

Publication type:

Article

Doxorubicin-Induced Cardiotoxicity and the Emerging Role of SGLT2 Inhibitors: From Glycemic Control to Cardio-Oncology.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 681, doi. 10.3390/ph18050681

By:

Goje, Iacob-Daniel;
Goje, Greta-Ionela;
Ordodi, Valentin Laurențiu;
Ciobotaru, Valentina Gabriela;
Ivan, Vlad Sabin;
Buzaș, Roxana;
Tunea, Oana;
Bojin, Florina;
Lighezan, Daniel-Florin

Publication type:

Article

SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4780, doi. 10.3390/ijms26104780

By:

Greco, Alessandra;
Canale, Maria Laura;
Quagliariello, Vincenzo;
Oliva, Stefano;
Tedeschi, Andrea;
Inno, Alessandro;
De Biasio, Marzia;
Bisceglia, Irma;
Tarantini, Luigi;
Maurea, Nicola;
Navazio, Alessandro;
Corda, Marco;
Iacovoni, Attilio;
Colivicchi, Furio;
Grimaldi, Massimo;
Oliva, Fabrizio

Publication type:

Article

Sodium–Glucose Cotransporter 2 Inhibitors in Aortic Stenosis: Toward a Comprehensive Cardiometabolic Approach.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4494, doi. 10.3390/ijms26104494

By:

Karakasis, Paschalis;
Theofilis, Panagiotis;
Patoulias, Dimitrios;
Vlachakis, Panayotis K.;
Pamporis, Konstantinos;
Sagris, Marios;
Ktenopoulos, Nikolaos;
Kassimis, George;
Antoniadis, Antonios P.;
Fragakis, Nikolaos

Publication type:

Article

Sodium-glucose cotransporter 2 inhibitors in transthyretin amyloid cardiomyopathy: navigating potential benefits and uncertainties.

Published in:

Current Medical Research & Opinion, 2025, v. 41, n. 4, p. 657, doi. 10.1080/03007995.2025.2495167

By:

Karakasis, Paschalis

Publication type:

Article

Evaluating the renoprotective effectiveness of sodium-glucose co-transporter 2 inhibitor therapy in patients with chronic kidney disease: a prospective study.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2024, v. 81, n. 1, p. 39, doi. 10.2298/VSP230805061K

By:

Ristanović, Vidna Karadžić;
Gajić, Selena;
Bontić, Ana;
Pavlović, Jelena;
Kezić, Aleksandra;
Radovanović, Jovana;
Radović, Milan

Publication type:

Article

Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure.

Published in:

Journal of Women's Health (15409996), 2023, v. 32, n. 11, p. 1219, doi. 10.1089/jwh.2023.0059

By:

Hammer, Andreas;
Hofer, Felix;
Kazem, Niema;
Koller, Lorenz;
Steinacher, Eva;
Baumer, Ulrike;
Wollmann, Felix;
Kautzky-Willer, Alexandra;
Beitl, Klara;
Remer, Franziska;
Hengstenberg, Christian;
Niessner, Alexander;
Sulzgruber, Patrick

Publication type:

Article

Cover Feature: Diarylcuprates for Selective Syntheses of Multifunctionalized Ketones from Thioesters under Mild Conditions (Chem. Eur. J. 26/2022).

Published in:

Chemistry - A European Journal, 2022, v. 28, n. 26, p. 1, doi. 10.1002/chem.202201013

By:

Kato, Daiki;
Murase, Tomoya;
Talode, Jalindar;
Nagae, Haruki;
Tsurugi, Hayato;
Seki, Masahiko;
Mashima, Kazushi

Publication type:

Article

Diarylcuprates for Selective Syntheses of Multifunctionalized Ketones from Thioesters under Mild Conditions.

Published in:

Chemistry - A European Journal, 2022, v. 28, n. 26, p. 1, doi. 10.1002/chem.202200474

By:

Kato, Daiki;
Murase, Tomoya;
Talode, Jalindar;
Nagae, Haruki;
Tsurugi, Hayato;
Seki, Masahiko;
Mashima, Kazushi

Publication type:

Article

Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Published in:

Osteoporosis International, 2023, v. 34, n. 12, p. 2013, doi. 10.1007/s00198-023-06908-2

By:

Wang, Xin;
Zhang, Fengyi;
Zhang, Yufeng;
Zhang, Jiayi;
Sheng, Yingli;
Wang, Wenbo;
Li, Yujie

Publication type:

Article

Effects of oral antidiabetic agents on the renin–angiotensin–aldosterone system.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 6, p. 801, doi. 10.1007/s00228-025-03830-w

By:

Yang, Xifeng;
Qi, Yijie;
Hao, Jinxuan;
Wei, Hongxia;
Li, Zhe;
Xu, Ming;
Zhang, Yi;
Liu, Yunfeng

Publication type:

Article

Sodium-glucose cotransporter 2 inhibitors and contrast-induced nephropathy risk: a meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 3, p. 337, doi. 10.1007/s00228-024-03799-y

By:

Fan, Gang;
Lin, Lin;
Zuo, Hong;
Yan, Rui;
Xu, Chao

Publication type:

Article

Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 2, p. 217, doi. 10.1007/s00228-024-03779-2

By:

Mitsuboshi, Satoru;
Hitoshi, Kotaro;
Ominato, Ai;
Kinoshita, Teruhisa;
Sugimoto, Yuka;
Kajiwara-Morita, Ayami;
Urata, Motoki;
Sato, Koji;
Sakamaki, Toshiyuki

Publication type:

Article

Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 12, p. 1959, doi. 10.1007/s00228-024-03759-6

By:

Xu, Bo;
Zhou, Jiecan

Publication type:

Article

Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 951, doi. 10.1007/s00228-024-03660-2

By:

Tanashat, Mohammad;
Manasrah, Almothana;
Abouzid, Mohamed

Publication type:

Article

Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 613, doi. 10.1007/s00228-024-03623-7

By:

Cai, Dabei;
Chen, Qianwen;
Mao, Lipeng;
Xiao, Tingting;
Wang, Yu;
Gu, Qingqing;
Wang, Qingjie;
Ji, Yuan;
Sun, Ling

Publication type:

Article

The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 563, doi. 10.1007/s00228-024-03631-7

By:

Wang, Yueping;
Zhou, Xian

Publication type:

Article

Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 11, p. 1465, doi. 10.1007/s00228-023-03561-w

By:

Guo, Nuojin;
Shi, Hekai;
Zhang, Hao;
Wang, Hua

Publication type:

Article

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 1, p. 127, doi. 10.1007/s00228-023-03586-1

By:

Zachou, Maria;
Flevari, Pagona;
Nasiri-Ansari, Narjes;
Varytimiadis, Constantinos;
Kalaitzakis, Evangelos;
Kassi, Eva;
Androutsakos, Theodoros

Publication type:

Article

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022).

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1239, doi. 10.1007/s00228-023-03539-8

By:

Lin, Jialing;
Pearson, Sallie-Anne;
Greenfield, Jerry R.;
Park, Kyeong Hye;
Havard, Alys;
Brieger, David;
Day, Richard O.;
Falster, Michael O.;
de Oliveira Costa, Juliana

Publication type:

Article

Safety of SGLT2 inhibitors in patients with different glomerular diseases treated with immunosuppressive therapies.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 961, doi. 10.1007/s00228-023-03508-1

By:

Elkeraie, Ahmed;
Zyada, Rowan;
Elrggal, Mahmoud E.;
Elrggal, Mohamed

Publication type:

Article

Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 859, doi. 10.1007/s00228-023-03490-8

By:

Li, Mengnan;
Zhang, Jian;
Yang, Guimei;
Zhang, Jiaxin;
Han, Minmin;
Zhang, Yi;
Liu, Yunfeng

Publication type:

Article

Bridging cardiology and oncology in the era of precision medicine.

Published in:

Basic Research in Cardiology, 2025, v. 120, n. 1, p. 1, doi. 10.1007/s00395-025-01097-x

By:

Rassaf, Tienush

Publication type:

Article

Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.

Published in:

Basic Research in Cardiology, 2024, v. 119, n. 5, p. 751, doi. 10.1007/s00395-024-01067-9

By:

Chen, Sha;
Wang, Qian;
Bakker, Diane;
Hu, Xin;
Zhang, Liping;
van der Made, Ingeborg;
Tebbens, Anna M.;
Kovácsházi, Csenger;
Giricz, Zoltán;
Brenner, Gábor B.;
Ferdinandy, Peter;
Schaart, Gert;
Gemmink, Anne;
Hesselink, Matthijs K. C.;
Rivaud, Mathilde R.;
Pieper, Michael P.;
Hollmann, Markus W.;
Weber, Nina C.;
Balligand, Jean-Luc;
Creemers, Esther E.

Publication type:

Article

Perspective: mitochondrial STAT3 in cardioprotection.

Published in:

Basic Research in Cardiology, 2023, v. 118, n. 1, p. 1, doi. 10.1007/s00395-023-01003-3

By:

Kleinbongard, Petra

Publication type:

Article

Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization.

Published in:

Basic Research in Cardiology, 2019, v. 114, n. 3, p. N.PAG, doi. 10.1007/s00395-019-0733-2

By:

Baker, Hana E.;
Kiel, Alexander M.;
Luebbe, Samuel T.;
Simon, Blake R.;
Earl, Conner C.;
Regmi, Ajit;
Roell, William C.;
Mather, Kieren J.;
Tune, Johnathan D.;
Goodwill, Adam G.

Publication type:

Article

Long-Term Mortality and SGLT2 Inhibitors in Type 2 Diabetes with and without Renal Impairment: An Observational Cohort Study.

Published in:

Medical Principles & Practice, 2024, v. 33, n. 3, p. 251, doi. 10.1159/000537850

By:

Al-Muhaiteeb, Abdullah;
Alahmad, Barrak;
Abu-Farha, Mohamed;
Abubaker, Jehad;
Thanaraj, Thangavel A.;
Ali, Hamad;
Al-Mulla, Fahd;
Qaddoumi, Mohammad

Publication type:

Article

Semaglutide May Reduce Alzheimer's Risk in Adults with T2D: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Semaglutide Linked with Reduced Risk of Alzheimer Disease in Large Observational Study.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Two Medication Classes Reduce CV, Liver Events in Persons with T2D, MASLD: Daily Dose.

Published in:: Patient Care (Online), 2024, p. 2
Publication type:: Article

SGLT2i Use and Improved QoL, Functional Capacity in Adults With HF: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

SGLT2 Inhibitor Use Improves Quality of Life, Functional Capacity in Patients with Heart Failure.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article

SGLT2 Inhibitors Outperformed Other Oral Antidiabetic Drugs for Persons with T2D, NAFLD: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

SGLT2 Inhibitors Outperformed Other Oral Antidiabetic Drugs for Patients with T2D and NAFLD, According to New Research.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Differential effect of canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice.

Published in:

Biochemical Journal, 2022, v. 479, n. 3, p. 425, doi. 10.1042/BCJ20210700

By:

Hiroko Otsuka;
Hisashi Yokomizo;
Shintaro Nakamura;
Yoshihiro Izumi;
Masatomo Takahashi;
Sachiko Obara;
Motonao Nakao;
Yosuke Ikeda;
Naoichi Sato;
Ryuichi Sakamoto;
Yasutaka Miyachi;
Takashi Miyazawa;
Takeshi Bamba;
Yoshihiro Ogawa

Publication type:

Article

The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice.

Published in:

Biochemical Journal, 2020, v. 477, n. 12, p. 2347, doi. 10.1042/BCJ20200278

By:

Day, Emily A.;
Ford, Rebecca J.;
Lu, Jessie H.;
Lu, Rachel;
Lundenberg, Lucie;
Desjardins, Eric M.;
Green, Alex E.;
Lally, James S. V.;
Schertzer, Jonathan D.;
Steinberg, Gregory R.

Publication type:

Article

Unlocking Heart Failure's Secret Weapon: The Transformative Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure with Reduced Ejection Fraction.

Published in:

Zagazig University Medical Journal, 2024, v. 30, p. 4952, doi. 10.21608/zumj.2024.276111.3242

By:

Wageeh, Shaimaa;
Othman, Basant Monier;
El-Awady, Waleed Salem;
Shehata, Islam Elsayed

Publication type:

Article

The changes of oxidative stress markers and Vitamin E in patients with diabetes using SGLT2 inhibitors.

Published in:

2024

By:

Padalkar, Pradnya

Publication type:

Letter to the Editor

The changes of oxidative stress markers and vitamin E in patients with diabetes using SGLT2 inhibitors.

Published in:

International Journal of Medical Biochemistry, 2023, v. 6, n. 3, p. 185, doi. 10.14744/ijmb.2023.20053

By:

Buyukaydin, Banu;
Ozer, Omer Faruk;
Ozder, Aclan;
Yildiz, Caner

Publication type:

Article

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

Published in:

JMIR Research Protocols, 2024, v. 13, p. 1, doi. 10.2196/56067

By:

Nielsen, Steffen Flindt;
Duus, Camilla Lundgreen;
Buus, Niels Henrik;
Bech, Jesper Nørgaard;
Mose, Frank Holden

Publication type:

Article

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).

Published in:

JMIR Research Protocols, 2022, v. 11, n. 7, p. 1, doi. 10.2196/34206

By:

Feher, Michael;
Hinton, William;
Forbes, Anna;
Munro, Neil;
Joy, Mark;
Wheeler, David;
de Lusignan, Simon

Publication type:

Article

The role of point-of-care ketone testing in the hospital.

Published in:

Medical Laboratory Observer (MLO), 2023, v. 55, n. 6, p. 1

By:

Begos, Dennis

Publication type:

Article

Empowering self-management: exploring self-care practices in heart failure patients.

Published in:

Pamukkale Medical Journal, 2024, v. 17, n. 3, p. 456, doi. 10.31362/patd.1411566

By:

Tekin, Işık;
Büber, İpek

Publication type:

Article